In an effort to limit the further development of antibiotic resistant bacteria, the Food and Drug Administration (FDA) is initiating a plan to phase out the use of what it terms “medically important antimicrobials” in food production animals to enhance growth and improve feed efficiency. In a final guidance issued Dec. 11, the FDA laid out a plan for animal pharmaceutical companies to voluntarily revise the FDA-approved use conditions on the labels of products to remove such production indications as “growth promoting,” etc. The plan also calls for changing the current over-the-counter status to bring the remaining appropriate therapeutic uses under veterinary oversight and requiring a prescription for use. Read More

Leave a Reply